ATE342996T1 - Attenuierte herpesviren, herpesviren die eine aminosäuresequenz kodierende fremde dna enthalten,und diese enthaltende impfstoffe - Google Patents
Attenuierte herpesviren, herpesviren die eine aminosäuresequenz kodierende fremde dna enthalten,und diese enthaltende impfstoffeInfo
- Publication number
- ATE342996T1 ATE342996T1 AT97103457T AT97103457T ATE342996T1 AT E342996 T1 ATE342996 T1 AT E342996T1 AT 97103457 T AT97103457 T AT 97103457T AT 97103457 T AT97103457 T AT 97103457T AT E342996 T1 ATE342996 T1 AT E342996T1
- Authority
- AT
- Austria
- Prior art keywords
- herpes viruses
- foreign dna
- attenuate
- contain
- amino acid
- Prior art date
Links
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 title 2
- 241000700605 Viruses Species 0.000 title 2
- 150000001413 amino acids Chemical group 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
- 241001502481 Meleagrid alphaherpesvirus 1 Species 0.000 abstract 3
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16741—Use of virus, viral particle or viral elements as a vector
- C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16761—Methods of inactivation or attenuation
- C12N2710/16762—Methods of inactivation or attenuation by genetic engineering
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/823,102 US5068192A (en) | 1986-01-27 | 1986-01-27 | Attenuated pseudorabies virus which includes foreign DNA encoding an amino acid sequence |
| US88714086A | 1986-07-17 | 1986-07-17 | |
| US90288786A | 1986-09-02 | 1986-09-02 | |
| US93310786A | 1986-11-20 | 1986-11-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE342996T1 true ATE342996T1 (de) | 2006-11-15 |
Family
ID=27505864
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97103457T ATE342996T1 (de) | 1986-01-27 | 1987-01-23 | Attenuierte herpesviren, herpesviren die eine aminosäuresequenz kodierende fremde dna enthalten,und diese enthaltende impfstoffe |
| AT87901222T ATE164885T1 (de) | 1986-01-27 | 1987-01-23 | Abgeschwächte herpesviren, herpesviren, die eine für aminosäuresequenzen kodierende fremd-dns enthalten, sowie impfstoffe, die diese enthalten |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT87901222T ATE164885T1 (de) | 1986-01-27 | 1987-01-23 | Abgeschwächte herpesviren, herpesviren, die eine für aminosäuresequenzen kodierende fremd-dns enthalten, sowie impfstoffe, die diese enthalten |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0794257B1 (de) |
| AT (2) | ATE342996T1 (de) |
| CA (1) | CA1339468C (de) |
| DE (3) | DE3752389T2 (de) |
| LU (1) | LU91303I2 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0965639A1 (de) * | 1998-06-05 | 1999-12-22 | Boehringer Ingelheim Vetmedica Gmbh | Attenuierte Pestiviren |
| US7179473B2 (en) | 1998-06-05 | 2007-02-20 | Boehringer Ingelheim Vetmedica Gmbh | Attenuated pestiviruses |
| US7135561B2 (en) | 2001-09-06 | 2006-11-14 | Boehringer Ingelheim Vetmedica Gmbh | Infectious bovine viral diarrhea virus clone |
| UY31930A (es) | 2008-06-25 | 2010-01-29 | Boheringer Ingelheim Pharma Kg | Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante |
| US8846054B2 (en) | 2009-01-09 | 2014-09-30 | Boehringer Ingelheim Vetmedica, Inc. | Method of treating pregnant cows and/or heifers |
| CN103370079B (zh) | 2010-10-18 | 2016-08-10 | 英特维特国际股份有限公司 | 针对家禽中禽流感的火鸡疱疹病毒作为载体的疫苗 |
| CA3206983A1 (en) | 2011-10-21 | 2013-04-25 | Intervet International B.V. | Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens |
| WO2013057235A1 (en) | 2011-10-21 | 2013-04-25 | Intervet International B.V. | Recombinant nonpathogenic mdv vector providing multivalent immunity |
| EP4168043A1 (de) | 2020-06-17 | 2023-04-26 | Boehringer Ingelheim Vetmedica GmbH | Rekombinante hvt-vektoren zur expression von influenza-hämagglutinin und immunogenen zusammensetzungen sowie herstellung und verwendungen davon |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0190254A4 (de) * | 1984-07-05 | 1987-03-09 | Genex Corp | Kloniertes gen, verfahren zu dessen herstellung und seine verwendung. |
-
1987
- 1987-01-23 AT AT97103457T patent/ATE342996T1/de active
- 1987-01-23 AT AT87901222T patent/ATE164885T1/de not_active IP Right Cessation
- 1987-01-23 DE DE3752389T patent/DE3752389T2/de not_active Expired - Lifetime
- 1987-01-23 EP EP97103457A patent/EP0794257B1/de not_active Expired - Lifetime
- 1987-01-23 DE DE3752182T patent/DE3752182T2/de not_active Revoked
- 1987-01-23 DE DE19873752389 patent/DE122007000004I1/de active Pending
- 1987-01-26 CA CA000528117A patent/CA1339468C/en not_active Expired - Lifetime
-
2007
- 2007-01-12 LU LU91303C patent/LU91303I2/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE164885T1 (de) | 1998-04-15 |
| DE3752389D1 (de) | 2006-11-30 |
| LU91303I2 (fr) | 2007-03-12 |
| EP0794257A1 (de) | 1997-09-10 |
| DE3752389T2 (de) | 2007-06-14 |
| CA1339468C (en) | 1997-09-23 |
| DE3752182T2 (de) | 1998-08-06 |
| DE122007000004I1 (de) | 2007-05-24 |
| DE3752182D1 (de) | 1998-05-14 |
| EP0794257B1 (de) | 2006-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0332677A4 (en) | Attenuated herpes viruses, herpes viruses which include foreign dna encoding an amino acid sequence and vaccines containing same | |
| LU91303I2 (fr) | Gallivac HVT IBD- virus vivant recombinant vHVT013-69,au minimum 3,0 log 10 UFP | |
| ZA865277B (en) | Virus vaccine | |
| DE3684255D1 (de) | Thymidinkinase-deletionsmutanten von bovinem herpesvirus-1, diese enthaltende impfstoffe gegen bovine rhinotracheitis und verfahren zu deren herstellung und verwendung. | |
| CA2031164A1 (en) | Recombinant herpesvirus of turkeys and live vector vaccines derived thereof | |
| EP0275300A4 (de) | Rekombinanter impfstoff. | |
| ES2061708T3 (es) | Virus recombinante de la viruela de la gallina, vectores de expresion de proteinas heterologas y vacunas para aves de corral derivadas de este virus. | |
| DE68929467D1 (de) | HIV-2 Varianten | |
| DK672789A (da) | Nukleinsyresekvens samt rekombinant vaertscelle transformeret med samme | |
| BR9202024A (pt) | Virus de apivox recombinante,cultura de celulas eucariotica infectadas por um virus de avipox,vacina,sequencia de transferencia e plasmideo | |
| EP0261940A3 (de) | Pseudorabies-Impfstoffe und DNS-Vektoren zur Rekombination mit Poxviren | |
| NZ228409A (en) | Marek's disease virus used as a multifunctional live vaccine | |
| EP0507179A3 (en) | Equine herpes viruses (ehv) containing foreign dna, process for their preparation and their use as vaccines | |
| EP0289550A4 (de) | Impfstoff zur behandlung von hsv. | |
| ATE102650T1 (de) | Mutanten des infektioesen bovinen rhinotracheitisvirus, vakzine die sie enthalten, verfahren zu ihrer herstellung und ihrer verwendung. | |
| CA2012414A1 (en) | Hog cholera virus vaccine and diagnostic | |
| NO964874L (no) | Fusjonsglykoprotein fra HCMV og HSV | |
| EP0236977A3 (de) | Impfstoffe gegen Rindervirus-Diarrhoe und Schweine-Cholera | |
| EP0256677A3 (de) | Pseudorabiesvirus-Rekombinanten und ihre Verwendung zur Herstellung von Proteinen | |
| DK498387D0 (da) | Virus-dna-sekvens | |
| GR3007856T3 (de) | ||
| MX9102757A (es) | Vacuna de virus de enfermedad de marek sin celulas. | |
| AU7514087A (en) | Vaccine containing the protein f of the aids virus | |
| WO1989010965A3 (en) | Glycoprotein h of herpes viruses | |
| MX9709514A (es) | Viruses de fowlpox recombinantes y usos de los mismos. |